Predictions
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€3.42
11.10.22
11.10.22
-
11.10.23
11.10.23
-15.79%
15.10.22
15.10.22
Hornbach Holding AG & Co. KGaA
Start price
Target price
Perf. (%)
€68.85
11.10.22
11.10.22
€70.00
11.10.23
11.10.23
8.71%
18.11.22
18.11.22
Hornbach Baumarkt AG
Start price
Target price
Perf. (%)
€47.50
11.10.22
11.10.22
€50.00
-
12.10.22
12.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€45.25
11.10.22
11.10.22
-
11.10.23
11.10.23
-7.45%
30.10.22
30.10.22
Biohaven Pharmac.hldg Co.ltd.
Start price
Target price
Perf. (%)
€156.00
11.10.22
11.10.22
€160.00
-
03.10.22
03.10.22
Hornbach Holding AG & Co. KGaA
Start price
Target price
Perf. (%)
€68.25
11.10.22
11.10.22
-
11.10.23
11.10.23
-11.50%
12.10.23
12.10.23
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€20.47
11.10.22
11.10.22
-
11.10.23
11.10.23
38.45%
13.01.23
13.01.23
Hypoport SE
Start price
Target price
Perf. (%)
€88.85
11.10.22
11.10.22
€90.00
11.10.23
11.10.23
-2.98%
16.10.22
16.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Microsoft Corp.
Start price
Target price
Perf. (%)
€236.40
11.10.22
11.10.22
€300.00
11.10.23
11.10.23
29.23%
11.06.23
11.06.23
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€48.60
10.10.22
10.10.22
€53.00
10.10.23
10.10.23
-32.10%
11.10.23
11.10.23
TAL Education Group ADR
Start price
Target price
Perf. (%)
€3.93
10.10.22
10.10.22
-
10.10.23
10.10.23
51.40%
02.04.23
02.04.23
Deutsche Post AG
Start price
Target price
Perf. (%)
€32.34
10.10.22
10.10.22
-
10.10.23
10.10.23
35.58%
05.05.23
05.05.23
Higher risks for its business
EBIT decline/stagnation expected
Infineon Technologies AG
Start price
Target price
Perf. (%)
€24.01
10.10.22
10.10.22
€25.00
10.10.23
10.10.23
5.64%
18.10.22
18.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group